Quick Answer
ABVC BIOPHARMA, INC. reported Stockholders Equity of $11.11 million for fiscal year 2025.
ABVC BIOPHARMA, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $11.11M | +806.2% |
| 2024 | $1.23M | -21.1% |
| 2023 | $1.55M | -49.8% |
| 2022 | $3.10M | -65.0% |
| 2021 | $8.84M | +157.2% |
| 2020 | $3.44M | +2377.6% |
| 2019 | -$151.0K | +97.3% |
| 2018 | -$5.66M | -222.0% |
| 2017 | -$1.76M | -26.1% |
| 2017 | -$1.39M | +78.6% |
| 2016 | -$6.52M | -2.2% |
| 2016 | -$6.38M | -1107.2% |
| 2015 | $633.4K | -29.4% |
| 2015 | $897.0K | +2760.4% |
| 2014 | $31.4K | +101.7% |
| 2013 | -$1.88M | -14.4% |
| 2012 | -$1.64M | -12.3% |
| 2011 | -$1.46M | +51.1% |
| 2010 | -$2.99M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $12.06M | +634.3% | +71.9% |
| June 30, 2025 | $7.01M | +292.7% | +29.8% |
| March 31, 2025 | $5.40M | +218.0% | +340.8% |
| December 31, 2024 | $1.23M | -85.4% | -25.3% |
| September 30, 2024 | $1.64M | -82.0% | -8.1% |
| June 30, 2024 | $1.79M | +570.9% | +5.1% |
| March 31, 2024 | $1.70M | +1.7% | -79.7% |
| December 31, 2023 | $8.39M | +170.7% | -7.8% |
- ABVC BIOPHARMA, INC. showed an increase of +806.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, ABVC BIOPHARMA, INC.’s stockholders equity has grown by 471.2% (from -$2.99 million to $11.11 million).
- The most recent figure is from ABVC BIOPHARMA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: